Small-Cap REIT ETF ...
Health Care: Drugs
Clovis Oncology Inc (CLVS: NASDAQ)
$36.91 0.18 | 0.49%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 36.91 |
| 52 Week High | 40.27 |
| 52 Week Low | 11.19 |
| Avg. Daily Vol. (Mil) | 0.15 |
| Beta (3 year) | 0.00 |
| Share Related Items | |
| Mkt Cap (Mil) | 969.44 |
| Shares Out (Mil) | 26.27 |
| Float (Mil) | 10.66 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 11.00 |
| Current Ratio | 11.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 8.10 |
| Price/Cash Flow | -9.20 |
| Per Share Data | |
| Earnings | -2.74 |
| Sales | 0.00 |
| Book Value | 4.56 |
| Cash Flow | -4.00 |
| Business Summary | |
|---|---|
| Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. | |
| General Information | |
| 2525 28th Street
Suite 1100 Boulder, CO 80301 |
|
| www.clovisoncology.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 61 | |
| CEO: Patrick J. Mahaffy | |
| Short Interest | |
| Current Month (Mil) | 1.73 |
| Previous Month (Mil) | 1.88 |
| Short Interest Ratio (Days) | 15.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -80.10 |
| Return on Investments | -87.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with CLVS
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks With Big Insider Buy...
Latest CLVS Headlines from TheStreet
- 4 Stocks Spiking on Big Volume 04.10.13 | 02:04 pm
- Why This Fund Manager Is Short Ziopharm 03.22.13 | 07:03 am
- Celgene's Abraxane: Two Month Survival Boost In Pancreatic Cancer Trial 01.22.13 | 06:01 pm
- Nate Sadeghi's 2012 Biotech Stock Report Card 11.26.12 | 07:11 am
- Clovis Oncology: Pancreatic Cancer Drug Fails Late-Stage Test 11.12.12 | 05:11 am
- Celgene: Abraxane Boosts Pancreatic Cancer Survival 11.12.12 | 12:11 am
- 21 Most Volatile Biopharma Stocks Closing Out 2012 11.05.12 | 06:11 am
- Threshold's Pancreatic Cancer Drug May be Obsolete Before Launch 10.01.12 | 07:10 am
- Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data 09.25.12 | 08:09 am
- Biotech Stock Mailbag: Pending Sarepta Results, Cyclacel 09.21.12 | 08:09 am
Press Releases for CLVS
- Clovis Oncology Announces 2012 Operating Results And 2013 Objectives - Business Wire 02.28.13 | 04:02 pm
- Clovis Oncology To Present At The Cowen Health Care Conference In Boston - Business Wire 02.25.13 | 04:02 pm
- Clovis Oncology To Announce Fourth Quarter/Year End 2012 Financial Results And Host Webcast Conference Call On February 28 - Business Wire 02.14.13 | 04:02 pm
- Clovis Oncology Announces 2013 Objectives And Financial Guidance - Business Wire 01.07.13 | 06:01 am
- Clovis Oncology To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 04:01 pm
- Clovis Oncology Announces Negative Outcome Of CO-101 In Pivotal LEAP Pancreatic Cancer Study - Business Wire 11.12.12 | 12:11 am
- Clovis Oncology To Present At The Credit Suisse Annual Healthcare Conference - Business Wire 11.08.12 | 05:11 pm
- Clovis Oncology Announces Third Quarter 2012 Operating Results - Business Wire 11.05.12 | 04:11 pm
- Clovis Oncology To Announce Third Quarter 2012 Financial Results And Host Webcast Conference Call On November 5 - Business Wire 10.18.12 | 04:10 pm
- Clovis Oncology To Present At September Conferences In Boston And New York - Business Wire 08.29.12 | 08:08 am
Partner Headlines for CLVS
- Pre-Market Most Active for Nov 12, 2012 : TIE, UN, BAC, GILD, MT, CLVS, FB, JEF, GRPN, DCM, NKTR, QQQ - NASDAQ 11.12.12 | 01:11 pm
- Investing in Biotech Stocks? The Journey to Profits Requires a Good GPS - NASDAQ 08.31.12 | 04:08 pm
- 5 Pharmaceutical Companies With Insider Buying During August 14-16 - Seeking Alpha 08.19.12 | 05:08 am
- Clovis Oncology Announces FDA Acceptance of Investigational New Drug Application for Oral EGFR Mutant-Selective Inhibitor CO-1686 - Benzinga 01.19.12 | 04:01 pm
- 15 Stocks Insiders Are Bullish About - Seeking Alpha 11.25.11 | 06:11 am
